| 000 | 01847 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515114146.0 | ||
| 264 | 0 | _c20080512 | |
| 008 | 200805s 0 0 eng d | ||
| 022 | _a1532-8414 | ||
| 024 | 7 |
_a10.1016/j.cardfail.2007.11.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLakhdar, Rachid | |
| 245 | 0 | 0 |
_aSafety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials. _h[electronic resource] |
| 260 |
_bJournal of cardiac failure _cApr 2008 |
||
| 300 |
_a181-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Meta-Analysis; Review; Systematic Review | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xadministration & dosage |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aEchocardiography, Doppler |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVentricular Dysfunction, Left _xdiagnosis |
| 700 | 1 | _aAl-Mallah, Mouaz H | |
| 700 | 1 | _aLanfear, David E | |
| 773 | 0 |
_tJournal of cardiac failure _gvol. 14 _gno. 3 _gp. 181-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cardfail.2007.11.008 _zAvailable from publisher's website |
| 999 |
_c17880761 _d17880761 |
||